The efficacy of low dose radioiodine therapy in differentiated thyroid cancer patients

被引：0
|
作者：
Yoon, S. [1 ]
Choi, B. [1 ]
Hong, S. [1 ]
Joh, C. [1 ]
Yoon, J. [1 ]
Lee, K. [1 ]
So, E. [1 ]
机构：
[1] Ajou Univ, Med Ctr, Suwon 441749, South Korea
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2008年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S374 / S374
页数：1
相关论文
共 50 条
  • [41] EVALUATION OF LOW-DOSE RADIOIODINE ABLATION THERAPY IN POSTSURGICAL THYROID-CANCER PATIENTS
    RAMANNA, L
    WAXMAN, AD
    BRACHMAN, MB
    TANASESCU, DE
    SENSEL, N
    BRAUNSTEIN, GD
    CLINICAL NUCLEAR MEDICINE, 1985, 10 (11) : 791 - 795
  • [42] Efficacy of Low-Dose Radioiodine Ablation in Low- and Intermediate-Risk Differentiated Thyroid Cancer: A Retrospective Comparative Analysis
    Maria Gomez-Perez, Ana
    Garcia-Aleman, Jorge
    Molina-Vega, Maria
    Sebastian Ochoa, Arantzazu
    Perez Garcia, Pilar
    Mancha Doblas, Isabel
    Tinahones, Francisco J.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (02)
  • [43] Impact of dose interruption on the efficacy of lenvatinib in a phase 3 study in patients with radioiodine- refractory differentiated thyroid cancer
    Tahara, Makoto
    Brose, Marcia S.
    Wirth, Lori J.
    Suzuki, Takuya
    Miyagishi, Hideaki
    Fujino, Katsuki
    Dutcus, Corina E.
    Gianoukakis, Andrew
    EUROPEAN JOURNAL OF CANCER, 2019, 106 : 61 - 68
  • [44] Different Radioiodine Dose for Remnant Thyroid Ablation in Patients With Differentiated Thyroid Cancer A Meta-analysis
    Song, Xinghua
    Meng, Zhaowei
    Jia, Qiang
    Zhang, Linlin
    Xu, Ke
    Tan, Jian
    Zhang, Guizhi
    Zheng, Wei
    Li, Xue
    Zhang, Jianping
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (10) : 774 - 779
  • [45] ''High-dose'' radioiodine therapy in advanced differentiated thyroid carcinoma
    Menzel, C
    Grunwald, F
    Schomburg, A
    Palmedo, H
    Bender, H
    Spath, G
    Biersack, HJ
    JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (09) : 1496 - 1503
  • [46] Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer
    Buscombe, John
    SEMINARS IN NUCLEAR MEDICINE, 2023, 53 (04) : 475 - 480
  • [47] Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer
    Bohuslavizki, KH
    Klutmann, S
    Bleckmann, C
    Brenner, W
    Lassmann, S
    Mester, J
    Henze, E
    Clausen, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (02) : 57 - 61
  • [48] Assessment of radioiodine clearance in patients with differentiated thyroid cancer
    Tabei, F.
    Asli, I. Neshandar
    Azizmohammadi, Z.
    Javadi, H.
    Assadi, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S343 - S343
  • [49] Assessment of radioiodine clearance in patients with differentiated thyroid cancer
    Tabei, Faraj
    Asli, Isa Neshandar
    Azizmohammadi, Zahra
    Javadi, Hamid
    Assadi, Majid
    RADIATION PROTECTION DOSIMETRY, 2012, 152 (04) : 323 - 327
  • [50] Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer
    Lassmann, M
    Luster, M
    Hänscheid, H
    Reiners, C
    JOURNAL OF NUCLEAR MEDICINE, 2005, 46 (05) : 899 - 899
12345